Jaron Nix on Unsplash
Analysis
Mexico’s R&D capabilities could boost the pharma industry’s economic position while spurring local technology development.
Healthcare industry: Lessons Learnt From the Pandemic
Video
Technology, R&D and collaboration were the three key elements that panelist found to be urgent to address in Mexico.
Healthcare Trends to Look for in 2021
Analysis
Global healthcare trends go beyond COVID-19. Find out what leaders of the industry foresee for this year.
by Mexico Health Review
News Article
Technology, R&D and collaboration were the three key elements that panelist found to be urgent to address in Mexico.
Sonia Perez
View from the Top
Sonia Pérez
Executive Director
UDIBI
UDIBI is a research and support laboratory for biochemical companies that also has capabilities as an authorized third party.
Sonia Pérez
View from the Top
Sonia Pérez
Executive Director
UDIBI
UDIBI is a part of the National School of Biological Sciences of the National Polytechnial Institute (IPN) and is an authorized third party
Laboratorios
Spotlight
INMEGEN, UNAM IBT and UDIBI are laboratories created to develop research.
MHS 2015
News Article
Mexico Health Summit 2015: Commercializing Research to Drive Innovation: Mexico’s Transition panel highlights
Dr. Sonia Mayra Pérez Tapia
View from the Top
Dr. Sonia Pérez
Executive Director
Unit of Research and Development in Bioprocesses (UDIBI)
The R&D process encompasses basic research, proof of concept, preclinical studies, and clinical trials
Subscribe to UDIBI